A*STAR and ETH Zürich have officially inked a Memorandum of Understanding (MOU) to deepen research collaboration in...
Japan-based Ono Pharmaceutical has entered into a research collaboration agreement with US-based startup Jorna The...
Japan-based PRISM BioLab, a leading discovery and development biotechnology company designing small molecule inhibitors ...
Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medic...
Harvest Integrated Research Organization (HiRO), a boutique global CRO, has signed an Memorandum of Understanding (MoU) ...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfu...
LG AI Research recently signed a joint research agreement at the Global Lounge of LG Science Park in Magok, Gangseo-gu,&...
Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...
What major plans are in store for the company (Asia Pacific region & global) in 2025? We’re going to keep del...
Drug discovery is a lengthy and costly process, typically requiring billions of dollars and nearly a decade to bring a d...
The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced a total investment of approxi...
Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...
Inventia Life Science, an innovator in 3D cell culture technologies, has announced the launch of RASTRUM Allegro, a...
AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...
Japanese pharmaceutical firm Daiichi Sankyo has established a state-of-the-art research laboratory in San Diego, Ca...
Takeda Pharmaceutical Company and the Tohoku University Drug Discovery Strategy Promotion Organization have entered into...
Eisai Co., Ltd. and Biogen Japan Ltd. have announced that Eisai has entered into a research collaboration agreement with...
Hong Kong-based Insilico Medicine, a global leading generative artificial intelligence (AI)-driven biotechnology company...
